Metabolic syndrome unravelling or unravelled?

Angela Sun, Amalia Mayo, Steve Turner

Research output: Contribution to journalReview article

Abstract

Metabolic syndrome (MS) is a composite of risk factors for cardiovascular disease including dyslipidaemia, insulin resistance, hypertension and usually associated with obesity. Initially MS was considered a condition of adults but is now recognised as having a prevalence of approximately 3.3% in children. The clinical relevance of MS in children is currently unknown but the morbidity associated with childhood obesity is well-recognised. This review describes the epidemiology of childhood MS, the underlying risk factors, possible developmental mechanisms and gives an overview of the current management of obesity in children.

Original languageEnglish
Pages (from-to)308-313
Number of pages6
JournalPaediatrics and Child Health (United Kingdom)
Volume25
Issue number7
Early online date21 Apr 2015
DOIs
Publication statusPublished - 31 Jul 2015

Fingerprint

Pediatric Obesity
Dyslipidemias
Insulin Resistance
Epidemiology
Cardiovascular Diseases
Obesity
Hypertension
Morbidity

Keywords

  • Epidemiology
  • Fetal development
  • Longitudinal studies
  • Metabolic syndrome
  • Obesity

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Metabolic syndrome unravelling or unravelled? / Sun, Angela; Mayo, Amalia; Turner, Steve.

In: Paediatrics and Child Health (United Kingdom), Vol. 25, No. 7, 31.07.2015, p. 308-313.

Research output: Contribution to journalReview article

Sun, Angela ; Mayo, Amalia ; Turner, Steve. / Metabolic syndrome unravelling or unravelled?. In: Paediatrics and Child Health (United Kingdom). 2015 ; Vol. 25, No. 7. pp. 308-313.
@article{618948a23da347b5bf0b8e8a9f5f5053,
title = "Metabolic syndrome unravelling or unravelled?",
abstract = "Metabolic syndrome (MS) is a composite of risk factors for cardiovascular disease including dyslipidaemia, insulin resistance, hypertension and usually associated with obesity. Initially MS was considered a condition of adults but is now recognised as having a prevalence of approximately 3.3{\%} in children. The clinical relevance of MS in children is currently unknown but the morbidity associated with childhood obesity is well-recognised. This review describes the epidemiology of childhood MS, the underlying risk factors, possible developmental mechanisms and gives an overview of the current management of obesity in children.",
keywords = "Epidemiology, Fetal development, Longitudinal studies, Metabolic syndrome, Obesity",
author = "Angela Sun and Amalia Mayo and Steve Turner",
note = "The authors would like to thank Dr Craig Oxley for his contributions to this review.",
year = "2015",
month = "7",
day = "31",
doi = "10.1016/j.paed.2015.03.013",
language = "English",
volume = "25",
pages = "308--313",
journal = "Paediatrics and Child Health",
issn = "1751-7222",
publisher = "Medicine Publishing",
number = "7",

}

TY - JOUR

T1 - Metabolic syndrome unravelling or unravelled?

AU - Sun, Angela

AU - Mayo, Amalia

AU - Turner, Steve

N1 - The authors would like to thank Dr Craig Oxley for his contributions to this review.

PY - 2015/7/31

Y1 - 2015/7/31

N2 - Metabolic syndrome (MS) is a composite of risk factors for cardiovascular disease including dyslipidaemia, insulin resistance, hypertension and usually associated with obesity. Initially MS was considered a condition of adults but is now recognised as having a prevalence of approximately 3.3% in children. The clinical relevance of MS in children is currently unknown but the morbidity associated with childhood obesity is well-recognised. This review describes the epidemiology of childhood MS, the underlying risk factors, possible developmental mechanisms and gives an overview of the current management of obesity in children.

AB - Metabolic syndrome (MS) is a composite of risk factors for cardiovascular disease including dyslipidaemia, insulin resistance, hypertension and usually associated with obesity. Initially MS was considered a condition of adults but is now recognised as having a prevalence of approximately 3.3% in children. The clinical relevance of MS in children is currently unknown but the morbidity associated with childhood obesity is well-recognised. This review describes the epidemiology of childhood MS, the underlying risk factors, possible developmental mechanisms and gives an overview of the current management of obesity in children.

KW - Epidemiology

KW - Fetal development

KW - Longitudinal studies

KW - Metabolic syndrome

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=84930763166&partnerID=8YFLogxK

U2 - 10.1016/j.paed.2015.03.013

DO - 10.1016/j.paed.2015.03.013

M3 - Review article

AN - SCOPUS:84930763166

VL - 25

SP - 308

EP - 313

JO - Paediatrics and Child Health

JF - Paediatrics and Child Health

SN - 1751-7222

IS - 7

ER -